Editorial coverage for physicians, surgical groups, and the practices building peer-reviewed reputations.
HIPAA-aware approvals, FTC-compliant testimonials, FDA-fluent on health claims. We coordinate with your compliance counsel by default and write coverage that converts evaluation traffic without crossing a regulatory line. Real bylines in Forbes, Bloomberg, Medical Economics, Medscape, JAMA Network.
Four reasons specialty practices move from paid acquisition to editorial.
Practice growth where paid medical ads convert poorly.
Patients comparing physicians do not trust paid placements the way they trust named publications. Editorial coverage in Forbes, Modern Healthcare, and Medscape converts evaluation traffic at multiples of paid social. Specialty practices see the gap most starkly.
Peer credibility that drives referrals.
Physicians refer to physicians they have read about. JAMA Network, Medical Economics, and Modern Healthcare are open at lunch in every academic medical center. Coverage there is closer to a peer-reviewed citation than a marketing impression.
Patient trust signals during evaluation.
A surgical patient evaluating a robotic spine fellow will read the surgeon's published interviews before they book. Editorial placements function as trust scaffolding for the moment a prospective patient is closest to a decision.
Recruiting fellows and attendings.
Specialty practice growth depends on attending and fellowship recruitment. Coverage in Modern Healthcare and the trade press is read by the candidates a private practice cannot reach through standard recruiting channels.
What we work inside, by name.
Compliance is the work, not a wrapper around the work.
- HIPAA on patient stories
We never reference patient information without de-identification meeting the HIPAA Safe Harbor standard, or written authorization that meets 45 CFR 164.508. Patient stories are restructured around method, modality, or outcome class rather than identifiable detail.
- FTC endorsement guidelines (16 CFR Part 255)
Testimonials disclose material connections, never imply atypical results as typical, and never substitute for required clinical disclosures. We disclose by default, even when the rule does not strictly require it, because the standard for editorial trust is higher than the legal floor.
- FDA constraints on health claims
Health claims comply with FDA labeling and advertising rules, including off-label promotion limits for prescription products. For medical device and pharmaceutical clients, copy is reviewed against the approved indication before pitch and adapted to publication-specific editorial standards.
- State medical board advertising rules
California, New York, Florida, and Texas medical boards impose disclosure requirements on physician advertising that vary by specialty. We adapt by jurisdiction and require GC or compliance counsel sign-off on draft pitches when material claims are involved.
Headlines for medical engagements.
De-identified by default. Real client placements with attribution replace these at launch.
- ForbesPractice operations
Why a private cardiology group walked away from a hospital affiliation deal in the third round.
- BloombergPractice economics
The economics of physician-owned surgery centers in 2026: a four-state pattern analysis.
- Medical EconomicsTrade · Operations
How a four-physician orthopedic group rebuilt its referral pipeline after the loss of its largest referrer.
- MedscapeTrade · Specialty
Robotic spine fellowship retention: what attending pay structures actually predict.
- Modern HealthcareTrade · Practice models
Concierge medicine at scale: a multi-site practice on the operating model behind their growth.
- USA TODAYConsumer education
What patients should ask before scheduling a same-day surgical consultation.
Headlines de-identified per HIPAA. Full engagement narratives, with metrics and client quotes, live on the Results page.
Medical engagements scale from single placements through quarterly campaigns to annual partnerships. Investment is shared on application after the editorial brief.
Specific to medical practice engagements.
We de-identify to the HIPAA Safe Harbor standard or work from a written 45 CFR 164.508 authorization. Most case studies are written around method, modality, or outcome class rather than identifiable detail. Drafts are reviewed by your compliance lead before pitch. We have never had a placement raise a HIPAA concern in publication.
Yes. Testimonials disclose material connections, never imply atypical results as typical, and never substitute for required clinical disclosures. We follow 16 CFR Part 255 by default. For physicians who are influencers or have promotional relationships with device or pharma companies, we add disclosures that exceed the legal floor.
Generally no. Off-label promotion of prescription products is restricted by FDA. We will write about clinical decision-making, methodology, and on-label indications, but we do not produce content that promotes off-label use. For device or pharma sponsors, we route copy through your medical-legal review team.
Specialty practices are our strongest fit. Cardiology, orthopedics, neurosurgery, ophthalmology, dermatology, plastic surgery, and concierge medicine groups make up most of the medical roster. Primary care groups are selectively engaged, usually around access models or value-based care narratives rather than direct patient acquisition.
Tier-1: Forbes, Bloomberg, USA Today, WSJ. Trade and clinical: Medical Economics, Medscape, Modern Healthcare, JAMA Network commentary, Becker's Hospital Review, Healthcare Finance. Consumer: USA Today health, Wall Street Journal health, Forbes health for evaluation traffic.
Selectively, and only for existing engagement clients with prior counsel and risk management already engaged. Crisis work is a separate scope, runs on an emergency retainer, and requires coordination with your malpractice carrier and outside counsel.
We do not produce peer-reviewed clinical research. We work in the layer above: editorial coverage of clinical methodology, practice economics, specialty operations, and physician thought leadership. We coordinate with your academic affiliations on timing relative to peer-reviewed publication if a paper is in review.
Bring us your specialty's strongest method story. We will tell you which publication it lands on.
Thirty-minute editorial brief, no obligation. We tell you which publications are realistic for your story before you commit.